Ze'ev A Ronai (Ze'ev Ronai)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 21

Top Venues

Cell research

Nature communications

The EMBO journal

Cancer research

Sanford-Burnham Medical Research Institute

Hebrew University of Jerusalem (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sanford-Burnham Medical Research Institute Oct 04 2004

United States

Professor, :: Cancer Center

Technion Israel Institute of Technology Ruth and Bruce Rappaport Faculty of Medicine Jul 01 2014 - Jul 01 2018

Israel

Professor :: Rappaport School of Medicine

Mount Sinai School of Medicine Department of Oncological Sciences Sep 01 1998 - Jul 31 2005

United States

Professor :: Oncological Sciences

New York Medical College Sep 01 1994 - Sep 01 1998

United States

Associate Professor :: Biochemistry Cell Biology

New York Medical College Dec 01 1989 - Sep 01 1994

United States

Assistant Professor :: Biochemistry

Education History

Hebrew University of Jerusalem Jul 01 1982 - Nov 30 1985

Israel

PHD :: Immunology

Publications

Marzia Scortegagna, Yuanning Du, Linda M Bradley, Wang Kun, Napoleone Ferrara, Eytan Ruppin, Rabi Murad, Ze'ev A Ronai
Ubiquitin ligases Siah1a/2 control alveolar macrophage functions to limit carcinogen-induced lung adenocarcinoma. Cancer research (2023)
Yuan Liu, Jingwen Yang, Tianlu Wang, Mei Luo, Yamei Chen, Chengxuan Chen, Ze'ev A Ronai, Yubin Zhou, Eytan Ruppin, Leng Han
Expanding PROTACtable genome universe of E3 ligases. Nature communications 14 (1) (2023)
Carolina Silva, Ze'ev A Ronai
An exploitable Achilles heel of MITF? Cell research 33 (3) (2023)
Carolina Silva, Ze'ev A Ronai
An exploitable Achilles heel of MITF? Cell research 33 (3) (2023)
Hyungsoo Kim, Yongmei Feng, Rabi Murad, Joanna Pozniak, Carl Pelz, Yeqing Chen, Bhavik Dalal, Rosalie C Sears, Eduard Sergienko, Michael Jackson, Eytan Ruppin, Meenhard Herylyn, Curtis C Harris, Jean-Christophe Marine, Victoria Klepsch, Gottfried Baier, Ze'ev A Ronai
Melanoma-intrinsic NR2F6 activity regulates antitumor immunity. Science advances 9 (27) (2023)
Benjamin Van Espen, Htoo Zarni Oo, Colin Collins, Ladan Fazil, Napoleone Ferrara, Kevin Y Yip, Rabi Murad, Martin E Gleave, Ze'ev A Ronai
RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential. Molecular cancer research : MCR (2023)
Carolina Silva, Ze'ev A Ronai
An exploitable Achilles heel of MITF? Cell research (2022)
Sachin Verma, David Crawford, Ali Khateb, Yongmei Feng, Eduard Sergienko, Gaurav Pathria, Chen-Ting Ma, Steven H Olson, David Scott, Rabi Murad, Eytan Ruppin, Michael Jackson, Ze'ev A Ronai
NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling. Nature cell biology 24 (9) (2022)
Hyungsoo Kim, Heejung Kim, Yongmei Feng, Yan Li, Hironari Tamiya, Stefania Tocci, Ze'ev A Ronai
PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity. Science translational medicine 12 (551) (2021)
Gaurav Pathria, Sachin Verma, Jun Yin, David A Scott, Ze'ev A Ronai
MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction. EMBO reports 22 (3) (2021)
Jianglan Liu, Vito W Rebecca, Andrew V Kossenkov, Thomas Connelly, Jingjing Liu, Alexis Gutierrez, Min Xiao, Ling Li, Gao Zhang, Anastasia Samarkina, Delaine Zayasbazan, Jie Zhang, Chaoran Cheng, Zhi Wei, Gretchen M Alicea, Mizuho Fukunaga-Kalabis, Clemens Krepler, Pedro Aza-Blanc, Chih-Cheng Yang, Bela Delvadia, Cynthia Tong, Ye Huang, Maya Delvadia, Alice S Morias, Katrin Sproesser, Patricia Brafford, Joshua X Wang, Marilda Beqiri, Rajasekharan Somasundaram, Adina Vultur, Denitsa M Hristova, Lawrence W Wu, Yiling Lu, Gordon B Mills, Wei Xu, Giorgos C Karakousis, George X Xu, Lynn M Schuchter, Tara C Mitchell, Ravi K Amaravadi, Lawrence N Kwong, Dennie T Frederick, Genevieve Marie Boland, Joseph M Salvino, David W Speicher, Keith T Flaherty, Ze'ev A Ronai, Meenhard Herlyn
Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance. Cancer research 81 (20) (2021)
Ali Khateb, Anagha Deshpande, Yongmei Feng, Darren Finlay, Joo Sang Lee, Ikrame Lazar, Bertrand Fabre, Yan Li, Yu Fujita, Tongwu Zhang, Jun Yin, Ian Pass, Ido Livneh, Irmela Jeremias, Carol Burian, James R Mason, Ronit Almog, Nurit Horesh, Yishai Ofran, Kevin K Brown, Kristiina Vuori, Michael Jackson, Eytan Ruppin, Aniruddha J Deshpande, Ze'ev A Ronai
The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors. Nature communications 12 (1) (2021)
Bo-Rui Chen, Anagha Deshpande, Karina Barbosa, Maria Kleppe, Xue Lei, Narayana Yeddula, Pablo Sánchez Vela, Alexandre Rosa Campos, Robert J Wechsler-Reya, Anindya Bagchi, Soheil Meshinchi, Connie Eaves, Irmela Jeremias, Torsten Haferlach, David A Frank, Ze'ev A Ronai, Sumit Chanda, Scott A Armstrong, Peter D Adams, Ross L Levine, Aniruddha J Deshpande
A JAK/STAT-mediated inflammatory signaling cascade drives oncogenesis in AF10-rearranged AML. Blood 137 (24) (2021)
Ali Khateb, Ze'ev A Ronai
Lipid metabolism: new twists to the Yin and Yang of PKM2 in cancer. The EMBO journal 40 (22) (2021)
Yongmei Feng, Gaurav Pathria, Susanne Heynen-Genel, Michael Jackson, Brian James, Jun Yin, David A Scott, Ze'ev A Ronai
Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma. Molecular cancer therapeutics 20 (5) (2021)
Marzia Scortegagna, Kathryn Hockemeyer, Igor Dolgalev, Joanna Poźniak, Florian Rambow, Yan Li, Yongmei Feng, Roberto Tinoco, Dennis C Otero, Tongwu Zhang, Kevin Brown, Marcus Bosenberg, Linda M Bradley, Jean-Christophe Marine, Ioannis Aifantis, Ze'ev A Ronai
Siah2 control of T-regulatory cells limits anti-tumor immunity. Nature communications 11 (1) (2020)
Lee-Or Herzog, Beth Walters, Roberta Buono, J Scott Lee, Sharmila Mallya, Amos Fung, Honyin Chiu, Nancy Nguyen, Boyang Li, Anthony B Pinkerton, Michael R Jackson, Robert J Schneider, Ze'ev A Ronai, David A Fruman
Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax. British journal of cancer 124 (6) (2020)
Gaurav Pathria, Joo Sang Lee, Erez Hasnis, Kristofferson Tandoc, David A Scott, Sachin Verma, Yongmei Feng, Lionel Larue, Avinash D Sahu, Ivan Topisirovic, Eytan Ruppin, Ze'ev A Ronai
Translational reprogramming marks adaptation to asparagine restriction in cancer. Nature cell biology 21 (12) (2019)
Gaurav Pathria, David A Scott, Yongmei Feng, Joo Sang Lee, Yu Fujita, Gao Zhang, Avinash D Sahu, Eytan Ruppin, Meenhard Herlyn, Andrei L Osterman, Ze'ev A Ronai
Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival. The EMBO journal 37 (20) (2018)
Hyungsoo Kim, Ze'ev A Ronai
Rewired Notch/p53 by Numb'ing Mdm2. The Journal of cell biology 217 (2) (2018)
Honyin Chiu, Leandra V Jackson, Kwon Ik Oh, Annie Mai, Ze'ev A Ronai, Davide Ruggero, David A Fruman
The mTORC1/4E-BP/eIF4E Axis Promotes Antibody Class Switching in B Lymphocytes. Journal of immunology (Baltimore, Md. : 1950) 202 (2) (2018)

Ze'ev A Ronai.css-eqlu8i{font-size:small;padding-left:4px;} (Ze'ev Ronai)

Publication Activity (10 Years)

Top Topics

Top Venues

Ze'ev A Ronai (Ze'ev Ronai)